Browsing byAuthorLucas, MC

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 2 to 7 of 7< previous 
Issue DateTitleAuthor(s)
2016-01-05Intravital FRAP Imaging using an E-cadherin-GFP Mouse Reveals Disease- and Drug-Dependent Dynamic Regulation of Cell-Cell Junctions in Live Tissue.Erami, Z; Herrmann, D; Warren, SC; Nobis, M; McGhee, EJ; Lucas, MC; Leung, W; Reischmann, N; Mrowinska, A; Schwarz, JP; Kadir, S; Conway, JRW; Vennin, C; Karim, SA; Campbell, AD; Gallego-Ortega, D; Magenau, A; Murphy, KJ; Ridgway, RA; Law, AM; Walters, SN; Grey, ST; Croucher, DR; Zhang, L; Herzog, H; Hardeman, EC; Gunning, PW; Ormandy, CJ; Evans, TRJ; Strathdee, D; Sansom, OJ; Morton, JP; Anderson, KI; Timpson, P
2018-02-01'MCC' protein interacts with E-cadherin and β-catenin strengthening cell-cell adhesion of HCT116 colon cancer cells.Benthani, FA; Herrmann, D; Tran, PN; Pangon, L; Lucas, MC; Allam, AH; Currey, N; Al-Sohaily, S; Giry-Laterriere, M; Warusavitarne, J; Timpson, P; Kohonen-Corish, MRJ
2020-02MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma.Castillo, L; Young, AIJ; Mawson, A; Schafranek, P; Steinmann, AM; Nessem, D; Parkin, A; Johns, A; Chou, A; Law, AMK; Lucas, MC; Murphy, KJ; Deng, N; Gallego-Ortega, D; Caldon, CE; Australian Pancreatic Cancer Genome Initiative (APGI); Timpson, P; Pajic, M; Ormandy, CJ; Oakes, SR
2016-12-08MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib.Young, AIJ; Law, AMK; Castillo, L; Chong, S; Cullen, HD; Koehler, M; Herzog, S; Brummer, T; Lee, EF; Fairlie, WD; Lucas, MC; Herrmann, D; Allam, A; Timpson, P; Watkins, DN; Millar, EKA; O'Toole, SA; Gallego-Ortega, D; Ormandy, CJ; Oakes, SR
2022-08-06Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis.Papanicolaou, M; Parker, AL; Yam, M; Filipe, EC; Wu, SZ; Chitty, JL; Wyllie, K; Tran, E; Mok, E; Nadalini, A; Skhinas, JN; Lucas, MC; Herrmann, D; Nobis, M; Pereira, BA; Law, AMK; Castillo, L; Murphy, KJ; Zaratzian, A; Hastings, JF; Croucher, DR; Lim, E; Oliver, BG; Mora, FV; Parker, BL; Gallego-Ortega, D; Swarbrick, A; O'Toole, S; Timpson, P; Cox, TR
2017-04-05Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.Vennin, C; Chin, VT; Warren, SC; Lucas, MC; Herrmann, D; Magenau, A; Melenec, P; Walters, SN; Del Monte-Nieto, G; Conway, JRW; Nobis, M; Allam, AH; McCloy, RA; Currey, N; Pinese, M; Boulghourjian, A; Zaratzian, A; Adam, AAS; Heu, C; Nagrial, AM; Chou, A; Steinmann, A; Drury, A; Froio, D; Giry-Laterriere, M; Harris, NLE; Phan, T; Jain, R; Weninger, W; McGhee, EJ; Whan, R; Johns, AL; Samra, JS; Chantrill, L; Gill, AJ; Kohonen-Corish, M; Harvey, RP; Biankin, AV; Australian Pancreatic Cancer Genome Initiative (APGI),; Evans, TRJ; Anderson, KI; Grey, ST; Ormandy, CJ; Gallego-Ortega, D; Wang, Y; Samuel, MS; Sansom, OJ; Burgess, A; Cox, TR; Morton, JP; Pajic, M; Timpson, P